Company
LimmaTech Biologics
Developing Innovative Vaccines Against Antimicrobial Resistant Pathogens
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Legal name
- LimmaTech Biologics AG
Claim, correct or request removal
Record updated 28 September 2026
About
A clinical stage biotechnology company developing innovative vaccines targeting AMR with their lead focus on Shigella (Phase II) and clinical programs in Staphylococcus (Phase I) & Gonorrhoea (Phase I/II).
Loading relationship preview